Mike Murphy

Mike Murphy

@mitoredox.bsky.social

Our lab is interested in all things mitochondrial.

342 followers5 following50 posts

I have two post doctoral positions available in my lab funded by the Wellcome Trust to develop new chemical biology approaches to studying mitochondria. Would suit those with interest in both mitochondria and chemical biology. Advert below-please forward and repost! www.cam.ac.uk/jobs/researc...

cam.ac.ukResearch Associate x 2 (Fixed Term)The Medical Research Council Mitochondrial Biology Unit (MRC MBU), University of Cambridge, wishes to appoint two post-doctoral Research Associates to join the research group of Prof. Mike Murphy at t...

Very pleased to have presented the Keith Reimer Distinguished Lecture at the ISHR meeting in Birmingham this week. Recognition of the work we have done with Thomas Krieg over the past 15 years

Funding? I'm a simple academic, so I'll have to await someone smart to explain to me how "pausing" MRC and BBSRC funding is the action of a biomedical science superpower...?

Drs Cherrie Kong and Stephen Harmer (University of Bristol) are offering a fully funded PhD project, " For information and to apply: www.findaphd.com/phds/project.... For information including application preparation: cherrie.kong@bristol.ac.uk Application deadline: 15 December 2025

findaphd.comUnderstanding and slowing transverse tubule loss in heart failure at University of Bristol on FindAPhD.comPhD Project - Understanding and slowing transverse tubule loss in heart failure at University of Bristol, listed on FindAPhD.com

In Toronto today giving a seminar at the Sick Kids Research Institute on "Mitochondria in Ischemia-Reperfusion Injury: From Basic Science to Potential Therapies" Great to catch up with previous lab member now in Toronto - Thomas Hurd, Ellen Robb and Anna Dare.

Good day yesterday at the William Harvey Research Institute Research Day where I was honoured to receive the Derek Willoughby Medal and give a lecture. Great hospitality from Dunja Aksentijevic and Sir Mark Caulfield.

Series of interesting papers showing that haematopoietic stem cells can undergo damaging clonal haematopoiesis when they acquire mutations that enhance mitochondrial respiration - opening the way to using metformin - and my beloved MitoQ - to prevent this transition. doi.org/10.1038/s415...

doi.orgMitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesis - NatureMetformin may serve as a non-toxic intervention to inhibit mitochondrial metabolism and slow DNMT3A-R882 clonal haematopoiesis expansion, thus delaying or averting progression to acute myeloid le...

Shows convincingly that that obesity increases mitochondrial ROS by RET in the liver in vivo to drive insulin resistance. This is proposed to be due to defects in CoQ biosynthesis - some fascinating findings here that will take time to explore by the community.

Congratulations to Abigail Giles who was awarded the "The Richard J. Bing Award for Young Investigators" at the recent World Congress of the International Society For Heart Research in Japan. Well done Abigail!

Mike Murphy reposted

IMS-MRL External Seminar (Cambridge) Tuesday 6 May 2025 at 13.15 Professor Mike Murphy, Understanding how mitochondria contribute to ischaemia-reperfusion injury HOST: Professor Steve O’Rahilly Hybrid Seminar in the IMS-MRL Seminar Rooms (for IMS staff), Online for others

Glad to be a small part on this interesting paper from Milos Filipovic with actual work done by Jan Miljkovic and Alva Casey in my lab. Ergothioneine improves healthspan of aged animals by enhancing cGPDH activity through CSE-dependent persulfidation: Cell Metabolism www.cell.com/cell-metabol...

cell.comErgothioneine improves healthspan of aged animals by enhancing cGPDH activity through CSE-dependent persulfidationPetrovic et al. demonstrate that ergothioneine acts as an alternative substrate for cystathionine gamma-lyase, an H2S-producing enzyme, leading to an increase of protein persulfidation. The persulfida...

Regarding paper in Cell from Jessica Spinelli on rhodoquinone (RQ) in mammalian mitochondria. The implication is that the lower reduction potential will allow SDH to run to fumarate more easily under hypoxic conditions. The introduction of RQ in vivo was elegant and gave pharmacological effects.

I suspect some of these may be due to the enhanced antioxidant effects of RQ cf. UQ. With the findings of RQ in tissues I’m intrigued as the levels reported are very high. Moreover, the quantification was done by LC/MS not LC-MS/MS vs an internal standard. In my view this needs to be revisited.

It will also be interesting to see the enzymology of the short chain RQ analogue with UQ enzymes. The source of the putative in vivo RQ (diet? microbiome? endogenous?) will also be good to explore.